newsfilter
← Latest News
GlobeNewswire·

IBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd.

LOS ANGELES, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative